AKT1 and myeloid sarcoma: Indeed, their gene targets and associated pathways have shown that mir-142–3p, mir-98–5p, mir-629–5p, and mir-212–3p were found to be statistically significant, and their target pathways and genes, such as PI3K-Akt, MAPK, and JAK-STAT, also mostly converging towards PI3K-Akt, may have an important role in the pathogenesis of MS as well as being new molecular tools in the diagnosis, prognosis, and treatment of MS patients [120].